Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis

Authors: M. P. Cristelli, F. Cofán, N. Rico, J. C. Trullàs, C. Manzardo, F. Agüero, J. L. Bedini, A. Moreno, F. Oppenheimer, J. M. Miro, the CKD-H. Clinic Investigators

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Accurately determining renal function is essential for clinical management of HIV patients. Classically, it has been evaluated by estimating glomerular filtration rate (eGFR) with the MDRD-equation, but today there is evidence that the new Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation has greater diagnostic accuracy. To date, however, little information exists on patients with HIV-infection. This study aimed to evaluate eGFR by CKD-EPI vs. MDRD equations and to stratify renal function according to KDIGO guidelines.

Methods

Cross-sectional, single center study including adult patients with HIV-infection.

Results

Four thousand five hundred three patients with HIV-infection (864 women; 19%) were examined. Median age was 45 years (IQR 37–52), and median baseline creatinine was 0.93 mg/dL (IQR 0.82–1.05). A similar distribution of absolute measures of eGFR was found using both formulas (p = 0.548). Baseline median eGFR was 95.2 and 90.4 mL/min/1.73 m2 for CKD-EPI and MDRD equations (p < 0.001), respectively. Of the 4503 measurements, 4109 (91.2%) agreed, with a kappa index of 0.803. MDRD classified 7.3% of patients as “mild reduced GFR” who were classified as “normal function” with CKD-EPI. Using CKD-EPI, it was possible to identify “normal function” (>90 mL/min/1.73 m2) in 73% patients and “mild reduced GFR” (60–89 mL/min/1.73 m2) in 24.3% of the patients, formerly classified as >60 mL/min/1.73 m2 with MDRD.

Conclusions

There was good correlation between CKD-EPI and MDRD. Estimating renal function using CKD-EPI equation allowed better staging of renal function and should be considered the method of choice. CKD-EPI identified a significant proportion of patients (24%) with mild reduced GFR (60–89 mL/min/1.73 m2).
Literature
2.
go back to reference Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D’Arminio Monforte A, Fox Z, Lundgren JD, e group., EuroSIDA study. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663–71.CrossRefPubMed Mocroft A, Brettle R, Kirk O, Blaxhult A, Parkin JM, Antunes F, Francioli P, D’Arminio Monforte A, Fox Z, Lundgren JD, e group., EuroSIDA study. Changes in the cause of death among HIV positive subjects across Europe: results from the EuroSIDA study. AIDS. 2002;16(12):1663–71.CrossRefPubMed
3.
go back to reference Miro JM, Cofan F, Trullas JC, Manzardo C, Cervera C, Tuset M, Oppenheimer F, Brunet M, Moreno A, Campistol JM, Gatell JM. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(3):187–99.CrossRefPubMed Miro JM, Cofan F, Trullas JC, Manzardo C, Cervera C, Tuset M, Oppenheimer F, Brunet M, Moreno A, Campistol JM, Gatell JM. Renal dysfunction in the setting of HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(3):187–99.CrossRefPubMed
4.
go back to reference Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD, e Group., EuroSIDA Study. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24(11):1667–78.CrossRefPubMed Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD, e Group., EuroSIDA Study. Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS. 2010;24(11):1667–78.CrossRefPubMed
5.
go back to reference Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335(2):89–94.CrossRefPubMed Fernando SK, Finkelstein FO, Moore BA, Weissman S. Prevalence of chronic kidney disease in an urban HIV infected population. Am J Med Sci. 2008;335(2):89–94.CrossRefPubMed
6.
go back to reference Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, Serwadda D, Chen M, Wawer MJ, Gray RH. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr. 2010;55(4):491–4.CrossRefPubMedPubMedCentral Lucas GM, Clarke W, Kagaayi J, Atta MG, Fine DM, Laeyendecker O, Serwadda D, Chen M, Wawer MJ, Gray RH. Decreased kidney function in a community-based cohort of HIV-Infected and HIV-negative individuals in Rakai, Uganda. J Acquir Immune Defic Syndr. 2010;55(4):491–4.CrossRefPubMedPubMedCentral
7.
go back to reference Sorlí ML, Guelar A, Montero M, González A, Rodriguez E, Knobel H. Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr. 2008;48(4):506–8.CrossRefPubMed Sorlí ML, Guelar A, Montero M, González A, Rodriguez E, Knobel H. Chronic kidney disease prevalence and risk factors among HIV-infected patients. J Acquir Immune Defic Syndr. 2008;48(4):506–8.CrossRefPubMed
8.
go back to reference Odongo P, Wanyama R, Obol JH, Apiyo P, Byakika-Kibwika P. Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital, Northern Uganda. BMC Nephrol. 2015;16:43.CrossRefPubMedPubMedCentral Odongo P, Wanyama R, Obol JH, Apiyo P, Byakika-Kibwika P. Impaired renal function and associated risk factors in newly diagnosed HIV-infected adults in Gulu Hospital, Northern Uganda. BMC Nephrol. 2015;16:43.CrossRefPubMedPubMedCentral
9.
go back to reference Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21(18):2435–43.CrossRefPubMed Lucas GM, Mehta SH, Atta MG, Kirk GD, Galai N, Vlahov D, Moore RD. End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS. 2007;21(18):2435–43.CrossRefPubMed
10.
go back to reference Ryom L, Mocroft A, Lundgren J. HIV therapies and the kidney: some good, some not so good? Curr HIV/AIDS Rep. 2012;9(2):111–20.CrossRefPubMed Ryom L, Mocroft A, Lundgren J. HIV therapies and the kidney: some good, some not so good? Curr HIV/AIDS Rep. 2012;9(2):111–20.CrossRefPubMed
11.
go back to reference Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE, SBU GFR Review Group. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411–24.CrossRefPubMed Soveri I, Berg UB, Björk J, Elinder CG, Grubb A, Mejare I, Sterner G, Bäck SE, SBU GFR Review Group. Measuring GFR: a systematic review. Am J Kidney Dis. 2014;64(3):411–24.CrossRefPubMed
12.
go back to reference Delanaye P, Mariat C. The applicability of eGFR equations to different populations. Nat Rev Nephrol. 2013;9(9):513–22.CrossRefPubMed Delanaye P, Mariat C. The applicability of eGFR equations to different populations. Nat Rev Nephrol. 2013;9(9):513–22.CrossRefPubMed
13.
go back to reference Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, Alamartine E, Lucht F, Pottel H, Mariat C. Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS. 2013;27(10):1573–81.CrossRefPubMed Gagneux-Brunon A, Delanaye P, Maillard N, Fresard A, Basset T, Alamartine E, Lucht F, Pottel H, Mariat C. Performance of creatinine and cystatin C-based glomerular filtration rate estimating equations in a European HIV-positive cohort. AIDS. 2013;27(10):1573–81.CrossRefPubMed
14.
go back to reference Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012;61(3):302–9.CrossRefPubMedPubMedCentral Inker LA, Wyatt C, Creamer R, Hellinger J, Hotta M, Leppo M, Levey AS, Okparavero A, Graham H, Savage K, Schmid CH, Tighiouart H, Wallach F, Krishnasami Z. Performance of creatinine and cystatin C GFR estimating equations in an HIV-positive population on antiretrovirals. J Acquir Immune Defic Syndr. 2012;61(3):302–9.CrossRefPubMedPubMedCentral
15.
go back to reference Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Sep 17. [Epub ahead of print]. Lucas GM, Ross MJ, Stock PG, Shlipak MG, Wyatt CM, Gupta SK, Atta MG, Wools-Kaloustian KK, Pham PA, Bruggeman LA, Lennox JL, Ray PE, Kalayjian RC. Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2014 Sep 17. [Epub ahead of print].
16.
go back to reference AIDS Working Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Society of Nephrology (S.E.N.); Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC). Consensus document on the management of renal disease in HIV-infected patients. Nefrologia. 2014;34 Suppl 2:1–81. AIDS Working Group (GESIDA) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC); Spanish Society of Nephrology (S.E.N.); Spanish Society of Clinical Chemistry and Molecular Pathology (SEQC). Consensus document on the management of renal disease in HIV-infected patients. Nefrologia. 2014;34 Suppl 2:1–81.
17.
go back to reference Delanaye P, Mariat C, Maillard N, Krzesinski JM, Cavalier E. Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol. 2011;6(4):906–12.CrossRefPubMed Delanaye P, Mariat C, Maillard N, Krzesinski JM, Cavalier E. Are the creatinine-based equations accurate to estimate glomerular filtration rate in African American populations? Clin J Am Soc Nephrol. 2011;6(4):906–12.CrossRefPubMed
18.
go back to reference Group., Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:150. Group., Kidney Disease: Improving Global Outcomes (KDIGO) Chronic Kidney Disease Work. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:150.
19.
go back to reference Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Cabrera M, Quevedo-Aguado L, Fernández-Labandera C, Ruiz-Moraga M, Sainz-Gutiérrez JC, Gómez-Martínez P, Román-García J, Felices PV, Ruilope LM, Zanchetti A, et al. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors. J Hypertens. 2014;32(10):1970–8.CrossRefPubMed Sánchez-Chaparro MA, Calvo-Bonacho E, González-Quintela A, Cabrera M, Quevedo-Aguado L, Fernández-Labandera C, Ruiz-Moraga M, Sainz-Gutiérrez JC, Gómez-Martínez P, Román-García J, Felices PV, Ruilope LM, Zanchetti A, et al. Estimating the glomerular filtration rate in the Spanish working population: chronic kidney disease prevalence and its association with risk factors. J Hypertens. 2014;32(10):1970–8.CrossRefPubMed
20.
go back to reference Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9.CrossRefPubMedPubMedCentral Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5(6):1003–9.CrossRefPubMedPubMedCentral
21.
go back to reference Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C, Post FA e Group., UK CHIC/CKD* Study. Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients. Nephrol Dial Transplant. 2012;27(6):2291–7.CrossRefPubMed Ibrahim F, Hamzah L, Jones R, Nitsch D, Sabin C, Post FA e Group., UK CHIC/CKD* Study. Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients. Nephrol Dial Transplant. 2012;27(6):2291–7.CrossRefPubMed
22.
go back to reference Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, e Collaboration, CKD-EPI (Chronic Kidney Disease Epidemiology). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro 3rd AF, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J, e Collaboration, CKD-EPI (Chronic Kidney Disease Epidemiology). A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–12.CrossRefPubMedPubMedCentral
23.
go back to reference Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, e Collaboration., Chronic Kidney Disease Epidemiology. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.CrossRefPubMed Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F, e Collaboration., Chronic Kidney Disease Epidemiology. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766–72.CrossRefPubMed
24.
go back to reference Gilead Sciences Inc.Stribild (elvitegravir/cobicistat/tenofovir/emtricitabine) [package insert] Foster City, CA: 2012. Gilead Sciences Inc.Stribild (elvitegravir/cobicistat/tenofovir/emtricitabine) [package insert] Foster City, CA: 2012.
25.
go back to reference Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21(9):1119–27.CrossRefPubMed Mocroft A, Kirk O, Gatell J, Reiss P, Gargalianos P, Zilmer K, Beniowski M, Viard JP, Staszewski S, Lundgren JD. Chronic renal failure among HIV-1-infected patients. AIDS. 2007;21(9):1119–27.CrossRefPubMed
26.
go back to reference Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabié A, Poizot-Martin I, Katlama C, Brunet-François C, Yazdanpanah Y, Dellamonica P, e group., New AIDS Data. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6(7):1700–7.CrossRefPubMed Flandre P, Pugliese P, Cuzin L, Bagnis CI, Tack I, Cabié A, Poizot-Martin I, Katlama C, Brunet-François C, Yazdanpanah Y, Dellamonica P, e group., New AIDS Data. Risk factors of chronic kidney disease in HIV-infected patients. Clin J Am Soc Nephrol. 2011;6(7):1700–7.CrossRefPubMed
27.
go back to reference Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009;10(6):343–50.CrossRefPubMedPubMedCentral Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009;10(6):343–50.CrossRefPubMedPubMedCentral
28.
go back to reference Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23(2):741–6.CrossRefPubMed Emem CP, Arogundade F, Sanusi A, Adelusola K, Wokoma F, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23(2):741–6.CrossRefPubMed
29.
go back to reference Evans K, Coresh J, Bash LD, Gary-Webb T, Köttgen A, Carson K, Boulware LE. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26(3):899–908.CrossRefPubMed Evans K, Coresh J, Bash LD, Gary-Webb T, Köttgen A, Carson K, Boulware LE. Race differences in access to health care and disparities in incident chronic kidney disease in the US. Nephrol Dial Transplant. 2011;26(3):899–908.CrossRefPubMed
Metadata
Title
Estimation of renal function by CKD-EPI versus MDRD in a cohort of HIV-infected patients: a cross-sectional analysis
Authors
M. P. Cristelli
F. Cofán
N. Rico
J. C. Trullàs
C. Manzardo
F. Agüero
J. L. Bedini
A. Moreno
F. Oppenheimer
J. M. Miro
the CKD-H. Clinic Investigators
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0470-4

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue